Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
NCT04673981 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2025-09-02
Summary
Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found.
The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.
Conditions
- Head Cancer
- Neck Cancer
- Chronic Pain
Interventions
- DIAGNOSTIC_TEST
-
diagnostic tes for neuropathic pain
Thermotest and hot water, cold water (for the oral cavity), Von frey filament and the brush
Sponsors & Collaborators
-
University Hospital, Clermont-Ferrand
lead OTHER
Principal Investigators
-
Nathalie PHAM DANG · University Hospital, Clermont-Ferrand
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-31
- Primary Completion
- 2028-07-31
- Completion
- 2028-07-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
NCT04431778 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 ·Status: UNKNOWN ·Phase: NA
-
Paracetamol and Neuropathic Pain
NCT03559985 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
NCT02100046 ·Status: COMPLETED ·Phase: PHASE2
-
Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life
NCT03296111 ·Status: TERMINATED
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING
-
Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort
NCT05817591 ·Status: RECRUITING
-
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
NCT03773055 ·Status: TERMINATED ·Phase: PHASE2
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
4-aminopyridine Treatment for Nerve Injury
NCT03701581 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies
NCT03156595 ·Status: UNKNOWN ·Phase: NA
-
Quantitative Sensory Testing of the Lower Lip After Inferior Alveolar Nerve Block, and Evaluation of the Role of the Contra-lateral Inferior Alveolar Nerve
NCT01530074 ·Status: TERMINATED ·Phase: NA
-
Oral Ketamine Administration in Patients With Peripheral Neuropathic Pain
NCT00961194 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
NCT01316744 ·Status: UNKNOWN ·Phase: PHASE3
-
Exploration of Neuropathic Pain Induced by Oxaliplatin Electrophysiological Approach
NCT02827916 ·Status: COMPLETED ·Phase: NA
-
Acupuncture for Symptoms of Nerve Damage
NCT03183037 ·Status: COMPLETED ·Phase: NA
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
Intrathecal Ziconotide Antalgic Efficacy for Severe Refractory Neuropathic
NCT03942848 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase II Dose Titration Study in Patients With Neuropathic Pain
NCT00736151 ·Status: COMPLETED ·Phase: PHASE2
-
Surgical Treatment of Chronic Neuropathic Pain
NCT04287075 ·Status: TERMINATED
-
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
NCT01208545 ·Status: UNKNOWN
-
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
NCT04888455 ·Status: COMPLETED
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine in Splanchnic Nerve Neurolysis
NCT05291364 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors
NCT05378256 ·Status: COMPLETED ·Phase: NA